×
About 38,973 results

ALLMedicine™ Escherichia Coli Center

Research & Reviews  14,128 results

Two multistate outbreaks of a reoccurring Shiga toxin-producing Escherichia coli strain...
https://doi.org/10.1017/S0950268821002703
Epidemiology and Infection; Waltenburg MA, Schwensohn C et. al.

Jan 22nd, 2022 - Leafy green vegetables are a common source of Shiga toxin-producing Escherichia coli O157:H7 (STEC O157) foodborne illness outbreaks. Ruminant animals, primarily cattle, are the major reservoir of STEC O157. Epidemiological, traceback and field in...

Incidence, Demographic, and Seasonal Risk Factors of Infections Caused by Five Major En...
https://doi.org/10.1089/fpd.2021.0034
Foodborne Pathogens and Disease; John P, Varga C et. al.

Jan 21st, 2022 - In Canada, enteric infections cause significant health and economic burden. We evaluated the individual characteristics of laboratory-confirmed cases of Campylobacter spp. (n = 28,728), non-typhoidal Salmonella spp. (n = 22,640), Yersinia spp. (n ...

Recombinant protein Schistosoma japonicum-derived molecule attenuates dextran sulfate s...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678816
World Journal of Gastroenterology; Zhang LC, Wu XY et. al.

Jan 21st, 2022 - Inflammatory bowel disease (IBD) affects millions of people worldwide and has emerged as a growing problem in industrialized nations. The lack of therapeutic targets has limited the treatment of IBD. Studies found that parasitic nematode infection...

A Microbe-Derived Efflux Pump Inhibitor of the Resistance-Nodulation-Cell Division Prot...
https://doi.org/10.1021/acsinfecdis.1c00281
ACS Infectious Diseases; Tambat R, Mahey N et. al.

Jan 20th, 2022 - The use of efflux pump inhibitors (EPIs) as potentiators along with the traditional antibiotics assists in the warfare against antibiotic-resistant superbugs. Efflux pumps of the resistance-nodulation-cell division (RND) family play crucial roles ...

Expression of the DeaD RNA helicase is regulated at multiple levels through its long mR...
https://doi.org/10.1128/jb.00613-21
Journal of Bacteriology; Ojha S, Jain C

Jan 19th, 2022 - DEAD-box proteins (DBPs) are a prominent class of RNA remodeling proteins that alter RNA structure, a process they typically perform through an ATP-dependent RNA helicase activity. Although many DBPs have been characterized at the structural and f...

see more →

Guidelines  4 results

Consumption of raw or unpasteurized milk and milk products by pregnant women and children.
https://doi.org/10.1542/peds.2013-3502
Pediatrics , et. al.

Dec 18th, 2013 - Sales of raw or unpasteurized milk and milk products are still legal in at least 30 states in the United States. Raw milk and milk products from cows, goats, and sheep continue to be a source of bacterial infections attributable to a number of vir...

Guideline for phenotypic screening and confirmation of carbapenemases in Enterobacteria...
https://doi.org/10.1016/j.ijantimicag.2010.05.014
International Journal of Antimicrobial Agents; Cohen Stuart J, Leverstein-Van Hall MA et. al.

Jul 6th, 2010 - Adequate detection of carbapenemase-producing Enterobacteriaceae is crucial for infection control measures and appropriate choice of antimicrobial therapy. This guideline aims to improve the detection of carbapenemase-producing Enterobacteriaceae ...

Recommendations for diagnosis of shiga toxin--producing Escherichia coli infections by ...
https://www.ncbi.nlm.nih.gov/pubmed/19834454
MMWR. Recommendations and Reports : Morbidity and Mortali... Gould LH, Bopp C et. al.

Oct 17th, 2009 - Shiga toxin--producing Escherichia coli (STEC) are a leading cause of bacterial enteric infections in the United States. Prompt, accurate diagnosis of STEC infection is important because appropriate treatment early in the course of infection might...

Guideline for the investigation and initial therapy of diarrhea-negative hemolytic urem...
https://doi.org/10.1007/s00467-008-0964-1
Pediatric Nephrology (Berlin, Germany); Ariceta G, Besbas N et. al.

Sep 19th, 2008 - This guideline for the investigation and initial treatment of atypical hemolytic uremic syndrome (HUS) is intended to offer an approach based on opinion, as evidence is lacking. It builds on the current ability to identify the etiology of specific...

see more →

Drugs  1,015 results see all →

Clinicaltrials.gov  67 results

A Study of Three Different Doses of VAC52416 (ExPEC10V) in Adults Aged 60 to 85 Years in Stable Health
https://clinicaltrials.gov/ct2/show/NCT03819049

Jan 19th, 2022 - ExPEC10V (JNJ-69968054) is a 10-valent vaccine candidate in development for prevention of invasive extraintestinal pathogenic Escherichia coli (ExPEC) disease (IED) in adults 60 years of age and older. ExPEC10V consists of O-antigen polysaccharide...

Study of the Ecological and Evolutionary Dynamics of Escherichia Coli in the Digestive Commensal Flora
https://clinicaltrials.gov/ct2/show/NCT05153824

Dec 10th, 2021 - Escherichia Coli poses a major public health problem. E. Coli is not only a commensal of the digestive tract but also a major opportunistic pathogen, first cause of urinary tract infections, first cause of bacteremia. However, little is known abou...

Pre-delivery Administration of Azithromycin to Prevent Neonatal Sepsis & Death
https://clinicaltrials.gov/ct2/show/NCT03199547

Sep 24th, 2021 - other data elements, such as eligibility criteria or outcome measures. (Limit: 32,000 characters) Project title: Pre-delivery administration of azithromycin to prevent neonatal sepsis and death: a phase III double-blind randomized clinical trial A...

Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli-2 (EXPECT-2)
https://clinicaltrials.gov/ct2/show/NCT04117113

Sep 21st, 2021 - Janssen Research & Development is developing ExPEC10V, a 10-valent conjugate vaccine comprising the 10 most predominant O-polysaccharides of ExPEC. Invasive ExPEC Disease (IED) is defined as an acute illness consistent with bacterial infection tha...

Safety and Efficacy of EcoActive on Intestinal Adherent Invasive E. Coli in Patients With Inactive Crohn's Disease
https://clinicaltrials.gov/ct2/show/NCT03808103

Aug 24th, 2021 - The purpose of this study is to determine if EcoActive is safe and effective in people with Crohn's disease. EcoActive is a collection of bacteriophages. Bacteriophages (or phages) are viruses that infect only bacteria. The phages in EcoActive inf...

see more →

News  372 results

Infectious disease pop quiz: Clinical challenges for the ObGyn
https://www.mdedge.com/obgyn/article/248281/mixed-topics/infectious-disease-pop-quiz-clinical-challenges-obgyn
Emily Susan Edwards, MD, MS, Patrick Duff, MD

Nov 4th, 2021 - In this question-and-answer article (the first in a series), our objective is to reinforce for the clinician several practical points of management for common infectious diseases. The principal references for the answers to the questions are 2 tex.

Some Cord-Blood Products Marketed as Stem Cell Therapies Tainted With Bacteria
https://www.medscape.com/viewarticle/960494

Oct 11th, 2021 - NEW YORK (Reuters Health) - Cord-blood-derived products marketed for treatments that the U.S. Food and Drug Administration (FDA) has not approved may be contaminated with bacteria, a new government study shows. In an investigation of bacterial inf...

BMS Withdraws Romidepsin Relapsed/Refractory PTCL Indication in the United States
https://www.onclive.com/view/bms-withdraws-romidepsin-relapsed-refractory-ptcl-indication-in-the-united-states

Aug 3rd, 2021 - Bristol Myers Squibb (BMS) has made the decision to withdraw in the indication for romidepsin (Istodax) as a monotherapy for the treatment of adult patients with peripheral T-cell lymphoma (PTCL) who have previously received at least 1 therapy.1 ...

FDA Approves New Asparaginase Product for Leukemia
https://www.medscape.com/viewarticle/954149

Jul 2nd, 2021 - The US Food and Drug Administration (FDA) has approved a new version of asparaginase for use in children and adults who have developed hypersensitivity to asparaginase derived from Escherichia coli. The new product is Jazz Pharmaceutical's Rylaze ...

Serious infections arise in pediatric transplant patients
https://www.mdedge.com/infectiousdisease/article/242053/invasive-fungal-infections/serious-infections-arise-pediatric

Jun 24th, 2021 - Key clinical point: Fungal or bacterial bloodstream infections were common in children within 5 years of liver or kidney transplants; the overall incidence in the first year post-transplant was 1. 91 per 100 recipients per month.

see more →

Patient Education  3 results see all →